• FluTrackers.com Inc. does not provide medical advice. Information on this web site is collected from various internet resources, and the FluTrackers board of directors makes no warranty to the safety, efficacy, correctness or completeness of the information posted on this site by any author or poster. The information collated here is for instructional and/or discussion purposes only and is NOT intended to diagnose or treat any disease, illness, or other medical condition. Every individual reader or poster should seek advice from their personal physician/healthcare practitioner before considering or using any interventions that are discussed on this website. By continuing to access this website you agree to consult your personal physican before using any interventions posted on this website, and you agree to hold harmless FluTrackers.com Inc., the board of directors, the members, and all authors and posters for any effects from use of any medication, supplement, vitamin or other substance, device, intervention, etc. mentioned in posts on this website, or other internet venues referenced in posts on this website.
  • We are not asking for any donations. Do not donate to any entity who says they are raising funds for us.

Antibody-dependent cellular cytotoxicity and influenza virus

tetano

Editor, Senior Moderator
Curr Opin Virol. 2017 Jan 11;22:89-96. doi: 10.1016/j.coviro.2016.12.002. [Epub ahead of print]
[h=1]Antibody-dependent cellular cytotoxicity and influenza virus.[/h] Vanderven HA[SUP]1[/SUP], Jegaskanda S[SUP]1[/SUP], Wheatley AK[SUP]1[/SUP], Kent SJ[SUP]2[/SUP].
[h=3]Author information[/h]

[h=3]Abstract[/h] Antibodies are a key defence against influenza infection and disease, but neutralizing antibodies are often strain-specific and of limited utility against divergent or pandemic viruses. There is now considerable evidence that influenza-specific antibodies with Fc-mediated effector functions, such as antibody-dependent cellular cytotoxicity (ADCC), can assist in the clearance of influenza infection in vitro and in animal models. Further, ADCC-mediating antibodies that recognize a broad array of influenza strains are common in humans, likely as a result of being regularly exposed to influenza infections. The concept that influenza-specific ADCC can assist in the partial control of influenza infections in humans is gaining momentum. This review examines the utility of influenza-specific ADCC antibodies.
Copyright ? 2016 Elsevier B.V. All rights reserved.


PMID: 28088123 DOI: 10.1016/j.coviro.2016.12.002
[PubMed - as supplied by publisher]
 
Back
Top Bottom